
Cathy L. Graham
General Surgery | Surgical Oncology
970 Joe Frank Harris Pkwy SE Ste 120
Cartersville, GA 30120
Cartersville, GA 30120
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Prediction of Anthracycline Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer by the MammaPrint 70-Gene Signature for Patients Enrolled in the FLEX Study.
Journal: JCO precision oncology
Published: June 24, 2026
Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE.
Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE.
Journal: Journal of the National Cancer Institute
Published: February 28, 2026
Prospective investigation of amino acid transport and PSMA-targeted positron emission tomography for metastatic lobular breast carcinoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 21, 2024
Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904).
Journal: BMC medical informatics and decision making
Published: February 28, 2024
A Discordant Pattern of Uptake on 68 Ga-PSMA PET/CT Versus 18 F-Fluciclovine PET/CT in Radiation-Induced Hepatitis : Implications for Early Postradiotherapy Imaging-Based Response Assessment.
Journal: Clinical nuclear medicine
Published: February 02, 2023
A Tale of 3 Tracers: Contrasting Uptake Patterns of 18F-Fluciclovine, 68Ga-PSMA, and 18F-FDG in the Uterus and Adnexa.
Journal: Clinical nuclear medicine
Published: December 05, 2022
Minimally Invasive Intact Excision of High-Risk Breast Lesions and Small Breast Cancers: The Intact Percutaneous Excision (IPEX) Registry.
Journal: Annals of surgical oncology
Published: May 17, 2018
Evaluation of percutaneous vacuum assisted intact specimen breast biopsy device for ultrasound visualized breast lesions: Upstage rates and long term follow-up for high risk lesions and DCIS.
Journal: Breast (Edinburgh, Scotland)
Published: October 10, 2016
Jadomycins are cytotoxic to ABCB1-, ABCC1-, and ABCG2-overexpressing MCF7 breast cancer cells.
Journal: Anti-cancer drugs
Published: November 16, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026